AIMS/HYPOTHESIS: High sodium (HS) effects on hypertension are well established. Recent evidence implicates a relationship between HS intake and insulin resistance, even in the absence of hypertension. The aim of the current study was to determine whether loss of the vascular actions of insulin may be the driving factor linking HS intake to insulin resistance. METHODS: Sprague Dawley rats were fed a control (0.31% wt/wt NaCl) or HS (8.00% wt/wt NaCl) diet for 4 weeks and subjected to euglycaemic-hyperinsulinaemic clamp (10 mU min(-1) kg(-1)) or constant-flow pump-perfused hindlimb studies following an overnight fast. A separate group of HS rats was given quinapril during the dietary intervention and subjected to euglycaemic-hyperinsulinaemic clamp as above. RESULTS: HS intake had no effect on body weight or fat mass or on fasting glucose, insulin, endothelin-1 or NEFA concentrations. However, HS impaired whole body and skeletal muscle glucose uptake, in addition to a loss of insulin-stimulated microvascular recruitment. These effects were present despite enhanced insulin signalling (Akt) in both liver and skeletal muscle. Constant-flow pump-perfused hindlimb experiments revealed normal insulin-stimulated myocyte glucose uptake in HS-fed rats. Quinapril treatment restored insulin-mediated microvascular recruitment and muscle glucose uptake in vivo. CONCLUSIONS/ INTERPRETATION: HS-induced insulin resistance is driven by impaired microvascular responsiveness to insulin, and is not due to metabolic or signalling defects within myocytes or liver. These results imply that reducing sodium intake may be important not only for management of hypertension but also for insulin resistance, and highlight the vasculature as a potential therapeutic target in the prevention of insulin resistance.
AIMS/HYPOTHESIS: High sodium (HS) effects on hypertension are well established. Recent evidence implicates a relationship between HS intake and insulin resistance, even in the absence of hypertension. The aim of the current study was to determine whether loss of the vascular actions of insulin may be the driving factor linking HS intake to insulin resistance. METHODS:Sprague Dawley rats were fed a control (0.31% wt/wt NaCl) or HS (8.00% wt/wt NaCl) diet for 4 weeks and subjected to euglycaemic-hyperinsulinaemic clamp (10 mU min(-1) kg(-1)) or constant-flow pump-perfused hindlimb studies following an overnight fast. A separate group of HS rats was given quinapril during the dietary intervention and subjected to euglycaemic-hyperinsulinaemic clamp as above. RESULTS: HS intake had no effect on body weight or fat mass or on fasting glucose, insulin, endothelin-1 or NEFA concentrations. However, HS impaired whole body and skeletal muscle glucose uptake, in addition to a loss of insulin-stimulated microvascular recruitment. These effects were present despite enhanced insulin signalling (Akt) in both liver and skeletal muscle. Constant-flow pump-perfused hindlimb experiments revealed normal insulin-stimulated myocyte glucose uptake in HS-fed rats. Quinapril treatment restored insulin-mediated microvascular recruitment and muscle glucose uptake in vivo. CONCLUSIONS/ INTERPRETATION: HS-induced insulin resistance is driven by impaired microvascular responsiveness to insulin, and is not due to metabolic or signalling defects within myocytes or liver. These results imply that reducing sodium intake may be important not only for management of hypertension but also for insulin resistance, and highlight the vasculature as a potential therapeutic target in the prevention of insulin resistance.
Authors: Michael G Clark; Michelle G Wallis; Eugene J Barrett; Michelle A Vincent; Stephen M Richards; Lucy H Clerk; Stephen Rattigan Journal: Am J Physiol Endocrinol Metab Date: 2003-02 Impact factor: 4.310
Authors: Michelle A Vincent; Lucy H Clerk; Jonathan R Lindner; Wendie J Price; Linda A Jahn; Howard Leong-Poi; Eugene J Barrett Journal: Am J Physiol Endocrinol Metab Date: 2006-06 Impact factor: 4.310
Authors: Lucy H Clerk; Michelle A Vincent; Linda A Jahn; Zhenqi Liu; Jonathan R Lindner; Eugene J Barrett Journal: Diabetes Date: 2006-05 Impact factor: 9.461
Authors: Lei Zhang; Michelle A Vincent; Stephen M Richards; Lucy H Clerk; Stephen Rattigan; Michael G Clark; Eugene J Barrett Journal: Diabetes Date: 2004-02 Impact factor: 9.461
Authors: Lauren K Park; Elizabeth J Parks; Ryan J Pettit-Mee; Makenzie L Woodford; Thaysa Ghiarone; James A Smith; Allan R K Sales; Luis A Martinez-Lemus; Camila Manrique-Acevedo; Jaume Padilla Journal: J Appl Physiol (1985) Date: 2020-07-02
Authors: Dino Premilovac; Emily Attrill; Stephen Rattigan; Stephen M Richards; Jeonga Kim; Michelle A Keske Journal: Cardiovasc Res Date: 2019-03-01 Impact factor: 10.787
Authors: Michelle A Keske; Dino Premilovac; Eloise A Bradley; Renee M Dwyer; Stephen M Richards; Stephen Rattigan Journal: J Physiol Date: 2015-01-12 Impact factor: 5.182
Authors: Monica Tj Schütten; Yvo Ham Kusters; Alfons Jhm Houben; Hanneke E Niessen; Jos Op 't Roodt; Jean Ljm Scheijen; Marjo P van de Waardenburg; Casper G Schalkwijk; Peter W de Leeuw; Coen DA Stehouwer Journal: JCI Insight Date: 2020-03-26
Authors: Ryan D Russell; Katherine M Roberts-Thomson; Donghua Hu; Timothy Greenaway; Andrew C Betik; Lewan Parker; James E Sharman; Stephen M Richards; Stephen Rattigan; Dino Premilovac; Glenn D Wadley; Michelle A Keske Journal: Diabetologia Date: 2021-09-29 Impact factor: 10.122